Astrana Health, Inc. (ASTH)
USD 35.04
(-1.35%)
USD 35.04
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 68.22 Million | 82.12 Million | 70.33 Million | 46.16 Million | 13.91 Million | 26.1 Million |
| Net Income | 57.84 Million | 45.74 Million | 46.05 Million | 122.08 Million | 14.11 Million | 10.83 Million |
| Depreciation & Amortization | 17.74 Million | 17.54 Million | 17.51 Million | 18.35 Million | 18.28 Million | 19.3 Million |
| Deferred income taxes | -12.44 Million | -14.27 Million | 7.67 Million | 396 Thousand | -6.8 Million | -8.34 Million |
| Stock-based compensation | 22.04 Million | 16.1 Million | 6.74 Million | 3.38 Million | - | - |
| Change in working capital | -23.38 Million | -1.95 Million | -33.63 Million | 4.03 Million | -22.77 Million | -63.04 Million |
| Other non-cash items | 6.42 Million | 18.97 Million | 25.98 Million | -102.08 Million | 58.33 Million | 157.26 Million |
| Investing Cash Flow | -65.52 Million | -7.11 Million | 16.54 Million | 95.49 Million | -180.84 Million | -25.76 Million |
| Investments in PPE | -28.52 Million | -22.94 Million | -19.22 Million | -1.16 Million | -1.04 Million | -1.17 Million |
| Acquisitions | -7.53 Million | -18.45 Million | -3.9 Million | 31.42 Million | -49.37 Million | -16.67 Million |
| Investment purchases | -6.15 Million | -1.85 Million | -28 Million | -1.79 Million | -119 Million | -414.01 Thousand |
| Sales/Maturities of investments | 491 Thousand | 31.67 Million | 67.61 Million | 50.62 Million | -1.00 | - |
| Other Investing Activities | -23.79 Million | 4.46 Million | 56 Thousand | 16.4 Million | -11.42 Million | -7.5 Million |
| Financing Cash Flow | 3.42 Million | -20.08 Million | -47.74 Million | -51.69 Million | 163.3 Million | -11.2 Million |
| Debt repayment | -205.35 Million | -4.42 Million | -238.53 Million | -9.6 Million | -228.71 Million | -7.4 Million |
| Dividends payments | -62.07 Million | -14.03 Million | -31.08 Million | -51.31 Million | -61.71 Million | -17.75 Million |
| Common Stock Repurchased | -10.19 Million | -9.25 Million | -5.73 Million | -537 Thousand | -7.56 Million | -5.04 Million |
| Common Stock Issuance | 1.52 Million | 8.63 Million | 40.13 Million | 10.8 Million | 3.87 Million | 4.19 Million |
| Other Financing Activities | -5 Million | -4.61 Million | -2.15 Million | -1.03 Million | - | - |
| Accounts receivables | -20.56 Million | -33.96 Million | -21.63 Million | 3.01 Million | -5.8 Million | -28.62 Million |
| Accounts payables | -498 Thousand | -2.51 Million | 4.1 Million | 15.81 Million | -4.88 Million | -22.66 Million |
| Inventory | 12.15 Million | 27.61 Million | -2.1 Million | -7.71 Million | - | - |
| Other working capital | -14.47 Million | 6.91 Million | -14 Million | -7.08 Million | -12.08 Million | -11.75 Million |
| Cash at beginning of period | 288.02 Million | 233.09 Million | 193.97 Million | 104.01 Million | 106.89 Million | 119.77 Million |
| Cash at end of period | 294.15 Million | 288.02 Million | 233.09 Million | 193.97 Million | 103.26 Million | 106.89 Million |
| Capital Expenditure | -28.52 Million | -22.94 Million | -19.22 Million | -1.16 Million | -1.04 Million | -1.17 Million |
| Effect of forex changes on cash | - | - | - | - | -634.00 | - |
| Net cash flow / Change in cash | 6.12 Million | 54.93 Million | 39.12 Million | 89.96 Million | -3.62 Million | -12.88 Million |
| Free Cash Flow | 39.69 Million | 59.18 Million | 51.11 Million | 44.99 Million | 12.87 Million | 24.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.17 Million | 14.83 Million | -94 Thousand | 57.84 Million | 27.97 Million | 17.48 Million |
| Depreciation & Amortization | 7.44 Million | 5.09 Million | 4.9 Million | 17.74 Million | 4.3 Million | 4.24 Million |
| Deferred income taxes | -11 Thousand | -7.24 Million | -8.5 Million | -12.44 Million | -190 Thousand | -4.02 Million |
| Stock-based compensation | 7.39 Million | 5.74 Million | 8.67 Million | 22.04 Million | 5.7 Million | 4.21 Million |
| Change in working capital | -12.95 Million | -23.15 Million | 11.38 Million | -23.38 Million | -25.07 Million | 7.23 Million |
| Other non-cash items | 19.43 Million | 56.64 Million | 2.93 Million | 6.42 Million | 2.68 Million | -3.34 Million |
| Investing Cash Flow | -79.92 Million | -70.91 Million | -11.42 Million | -65.52 Million | -34.87 Million | -5.18 Million |
| Investments in PPE | -2.83 Million | -369 Thousand | -7.05 Million | -28.52 Million | -4.1 Million | -2.51 Million |
| Acquisitions | -63.93 Million | -50.52 Million | -1.83 Million | -7.53 Million | -5.72 Million | 350 Thousand |
| Investment purchases | -8.49 Million | -27 Thousand | -2.02 Million | -6.15 Million | -103 Thousand | -3.02 Million |
| Sales/Maturities of investments | - | - | 491 Thousand | 491 Thousand | - | - |
| Other Investing Activities | -4.65 Million | -19.99 Million | -997 Thousand | -23.79 Million | -24.94 Million | 2000.00 |
| Financing Cash Flow | 47.25 Million | 106.22 Million | 11.99 Million | 3.42 Million | -510 Thousand | -963 Thousand |
| Debt repayment | -52.63 Million | -106.32 Million | -204.39 Million | -205.35 Million | -351 Thousand | -308 Thousand |
| Dividends payments | -1.8 Million | -95 Thousand | -59.8 Million | -62.07 Million | -1.42 Million | -722 Thousand |
| Common Stock Repurchased | - | - | -503 Thousand | -10.19 Million | -150 Thousand | - |
| Common Stock Issuance | - | - | 272 Thousand | 1.52 Million | - | - |
| Other Financing Activities | -3.58 Million | 125 Thousand | -4.95 Million | -5 Million | - | - |
| Accounts receivables | -19.78 Million | -30.9 Million | 47.49 Million | -20.56 Million | -33.09 Million | 1.13 Million |
| Accounts payables | 24.76 Million | 905 Thousand | 2.42 Million | -498 Thousand | -601 Thousand | 1.28 Million |
| Inventory | - | - | 1.09 Million | 12.15 Million | -1.13 Million | -4.24 Million |
| Other working capital | -17.93 Million | 6.84 Million | -39.63 Million | -14.47 Million | 9.75 Million | 9.06 Million |
| Cash at beginning of period | 334.79 Million | 293.8 Million | 274.28 Million | 288.02 Million | 294.26 Million | 274.61 Million |
| Cash at end of period | 325.31 Million | 334.79 Million | 294.15 Million | 294.15 Million | 274.28 Million | 294.26 Million |
| Capital Expenditure | -2.83 Million | -369 Thousand | -7.05 Million | -28.52 Million | -4.1 Million | -2.51 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.48 Million | 40.98 Million | 19.86 Million | 6.12 Million | -19.98 Million | 19.65 Million |
| Free Cash Flow | 20.35 Million | 5.6 Million | 12.24 Million | 39.69 Million | 11.3 Million | 23.28 Million |
ALCOX
SBN
MBSS
2017
EHTH
INDR